According to GlobalData, ELUNIR is one of 45 product lines sold in the US coronary stents market; these product lines are sold by 8 different manufacturers. The price of the ELUNIR device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Coronary Stents - Medinol Ltd - ELUNIR

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Medinol apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Medinol overview

Medinol Ltd (Medinol) is a medical device company that researches, develops and manufactures cardiovascular intervention solutions. It offers products that include coronary stent system, bare metal stents, PTCA dilatation catheter, biliary metallic stent and self expanding peripheral stent. The comprises services comprise research, development, coating, quality control, regulatory affairs, clinical trials and studies, manufacturing, drug elution, traditional polymer coating services, marketing and sales. Medinol uses Flexx2 catheter technology, WiZeCell, eDES coating, and unique manufacturing technology to develop its products. Its stents are cut by water-jet laser from cobalt-chromium alloy panels. The company operates in Israel and the US. Medinol is headquartered in Tel Aviv, Israel.

For a complete picture of ELUNIR, Coronary Stents pricing in the US, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.